EUVIMEDEUVIMED entdecken
Crossref

Design and Optimization of Lysosome-Targeted β-Galactoside Senolytic Prodrugs: Harnessing the Aromatic Ring of Self-Immolative Linkers

Jie Liu, Xiaoke Liu, Haitian Fu, Chunjing Yu iD, Jing Hu iD, Junjie Fu iD, Jian Yin iD

Journal of Medicinal Chemistry · 2026

DOI: 10.1021/acs.jmedchem.5c01922 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2026. Verfasst von Jie Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, School of Biotechnology & School of Life Sciences and Health Engin…. Hauptthemen laut MEDLINE: Prodrugs, Galactosides, Lysosomes, Drug Design. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To improve senolytic efficacy and selectivity, we designed gemcitabine (Gem)-based galactoside prodrugs activated by senescence-associated β-galactosidase (SA-β-gal), bearing lysosome-targeting groups at the 3- and 5-positions of the self-immolative linker aromatic ring. This strategy avoids stereocenter formation and promotes faster, electron-donating-effect-driven drug release. Gal-dMor-Gem, with two morpholine groups, showed the strongest activity. Its senolytic index reached 16.1-56.7 across six senescent cell (SnC) models, a 2.8- to 3.7-fold improvement over the nontargeted SSK1. Gal-dMor-Gem released Gem faster and preferentially induced SnC apoptosis, as validated in a coculture model. Biodistribution studies confirmed its preferential accumulation and activation in senescent tissues. In senescent mice, Gal-dMor-Gem (0.5 mg/kg) surpassed SSK1 in restoring body weight, improving biochemical parameters, and reducing SA-β-gal, IL-6, and lamin B1 abnormalities in multiple organs. At 1.0 mg/kg, most markers returned to healthy levels. This work identifies Gal-dMor-Gem as a potent senolytic and highlights a generalizable strategy for developing targeted SA-β-gal-responsive prodrugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsGalactosidesLysosomesDrug DesignDeoxycytidineSenotherapeuticsAnimalsHumansMiceGemcitabinebeta-GalactosidaseCellular SenescenceApoptosisCell Line, TumorTissue DistributionStructure-Activity Relationship

Substanzen

ProdrugsGalactosidesbeta-galactosideDeoxycytidineGemcitabinebeta-GalactosidaseSenotherapeutics

Autor:innen und Institutionen

  • Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, School of Biotechnology & School of Life Sciences and Health Engineering, Jiangnan University, Lihu Avenue 1800, Wuxi, Jiangsu 214122, C…
  • Department of Nuclear Medicine, Affiliated Hospital of Jiangnan University, Wuxi 214122, China.
  • Wuxi School of Medicine, Jiangnan University, Wuxi 214122, China.
  • Innovation Center for Vaccine Engineering, Jiangnan University, Wuxi 214122, China.

ORCID-Profile: Chunjing Yu, Jing Hu, Junjie Fu, Jian Yin

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Liu, J., Liu, X., Fu, H., Yu, C., Hu, J., Fu, J., & Yin, J. (2026). Design and Optimization of Lysosome-Targeted β-Galactoside Senolytic Prodrugs: Harnessing the Aromatic Ring of Self-Immolative Linkers. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c01922

Vancouver

Liu J, Liu X, Fu H, Yu C, Hu J, Fu J, et al. Design and Optimization of Lysosome-Targeted β-Galactoside Senolytic Prodrugs: Harnessing the Aromatic Ring of Self-Immolative Linkers. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.5c01922

BibTeX
@article{Liu2026,
  author = {Liu, Jie and Liu, Xiaoke and Fu, Haitian and Yu, Chunjing and Hu, Jing and Fu, Junjie and Yin, Jian},
  title = {Design and Optimization of Lysosome-Targeted β-Galactoside Senolytic Prodrugs: Harnessing the Aromatic Ring of Self-Immolative Linkers},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  doi = {10.1021/acs.jmedchem.5c01922}
}
Kostenlos starten →